Search research articles
Contact Us
Filters
Showing results (91-100 of 122) with videos related to
Page
of 13
Sort By:
Cancer Cell
|
November 1, 2021
Human prostate cancer bone metastases have an actionable immunosuppressive microenvironment
Youmna Kfoury, Ninib Baryawno, Nicolas Severe, et al.
Blood
|
November 21, 2024
CD70 CAR T cells secreting an anti-CD33/anti-CD3 dual-targeting antibody overcome antigen heterogeneity in AML
Harrison J Silva, Grace Martin, Filippo Birocchi, et al.
Journal of Neurosurgery
|
January 22, 2026
Protocol for the systematic reduction of sterile surgical instrument waste: a single-institution prospective implementation and analysis
Timothy R West, Nicole A Perez, Kwaku Adubofour, et al.
Journal for Immunotherapy of Cancer
|
November 16, 2019
CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma
Bryan D Choi, Xiaoling Yu, Ana P Castano, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 2, 2025
IDH1-dependent m6A methylation defines transcriptomic heterogeneity in glioma
Syeda Maheen Batool, Hanna Lee, Koushik Muralidharan, et al.
American Journal of Hematology
|
October 23, 2024
Toxicities and outcome after CD19-directed chimeric antigen receptor T-cell therapy for secondary neurolymphomatosis
Leon D Kaulen, Philipp Karschnia, Sofia Doubrovinskaia, et al.
Cancers
|
June 12, 2026
IDH1-Associated m6A Methylation Is Linked to Transcriptomic Heterogeneity in Glioma
Syeda Maheen Batool, Hanna Lee, Koushik Muralidharan, et al.
Oncoimmunology
|
November 20, 2019
A novel in situ multiplex immunofluorescence panel for the assessment of tumor immunopathology and response to virotherapy in pediatric glioblastoma reveals a role for checkpoint protein inhibition
Joshua D Bernstock, Nunzio Vicario, Li Rong, et al.
Oncoimmunology
|
June 7, 2018
Temozolomide lymphodepletion enhances CAR abundance and correlates with antitumor efficacy against established glioblastoma
Carter M Suryadevara, Rupen Desai, Melissa L Abel, et al.
Biorxiv : the Preprint Server for Biology
|
April 16, 2025
Mapping the spatial architecture of glioblastoma from core to edge delineates niche-specific tumor cell states and intercellular interactions
Saad M Khan, Anthony Z Wang, Rupen R Desai, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 122) with videos related to
Sort By:
Page
of 13
Cancer Cell
|
November 1, 2021
Human prostate cancer bone metastases have an actionable immunosuppressive microenvironment
Youmna Kfoury, Ninib Baryawno, Nicolas Severe, et al.
Blood
|
November 21, 2024
CD70 CAR T cells secreting an anti-CD33/anti-CD3 dual-targeting antibody overcome antigen heterogeneity in AML
Harrison J Silva, Grace Martin, Filippo Birocchi, et al.
Journal of Neurosurgery
|
January 22, 2026
Protocol for the systematic reduction of sterile surgical instrument waste: a single-institution prospective implementation and analysis
Timothy R West, Nicole A Perez, Kwaku Adubofour, et al.
Journal for Immunotherapy of Cancer
|
November 16, 2019
CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma
Bryan D Choi, Xiaoling Yu, Ana P Castano, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 2, 2025
IDH1-dependent m6A methylation defines transcriptomic heterogeneity in glioma
Syeda Maheen Batool, Hanna Lee, Koushik Muralidharan, et al.
American Journal of Hematology
|
October 23, 2024
Toxicities and outcome after CD19-directed chimeric antigen receptor T-cell therapy for secondary neurolymphomatosis
Leon D Kaulen, Philipp Karschnia, Sofia Doubrovinskaia, et al.
Cancers
|
June 12, 2026
IDH1-Associated m6A Methylation Is Linked to Transcriptomic Heterogeneity in Glioma
Syeda Maheen Batool, Hanna Lee, Koushik Muralidharan, et al.
Oncoimmunology
|
November 20, 2019
A novel in situ multiplex immunofluorescence panel for the assessment of tumor immunopathology and response to virotherapy in pediatric glioblastoma reveals a role for checkpoint protein inhibition
Joshua D Bernstock, Nunzio Vicario, Li Rong, et al.
Oncoimmunology
|
June 7, 2018
Temozolomide lymphodepletion enhances CAR abundance and correlates with antitumor efficacy against established glioblastoma
Carter M Suryadevara, Rupen Desai, Melissa L Abel, et al.
Biorxiv : the Preprint Server for Biology
|
April 16, 2025
Mapping the spatial architecture of glioblastoma from core to edge delineates niche-specific tumor cell states and intercellular interactions
Saad M Khan, Anthony Z Wang, Rupen R Desai, et al.
Page
of 13